Recently, a study revealed the distinct immune microenvironment of lung adenocarcinoma in non-smokers and smokers, further explaining the poor response of non-smokers to PD-1/PD-L1 inhibitors (45). The gene discussed is CD274; the disease is lung adenocarcinoma.